New developments in melanoma genetics.

被引：35

作者：

Hayward N. ^{[1
]}

机构：

[1] Joint Experimental Oncology Programme of the Queensland Institute of Medical Research, University of Queensland and the Queensland Cancer Fund, PO Royal Brisbane Hospital, 4029, QLD

来源：

Current Oncology Reports | 2000年 / 2卷 / 4期

基金：

英国医学研究理事会;

关键词：

Melanoma; Plexiform Neurofibroma; Dysplastic Nevus; CDKN2A Mutation; Familial Melanoma;

D O I：

10.1007/s11912-000-0022-z

中图分类号：

学科分类号：

摘要：

Research over the last decade has unraveled many details of genetic susceptibility to melanoma. The most recent advances include the characterization of variants outside the coding region of the CDKN2A gene associated with melanoma predisposition. A mutation in the 5' untranslated region (UTR) of CDKN2A generates a novel upstream initiation codon that abrogates expression of p16, and a common polymorphism in the 3' UTR is associated with increasing familial risk of melanoma. Other studies have assessed CDKN2A mutation status and non-melanoma cancers, atypical nevi, and the development of multiple primary melanomas, and provided information valuable for screening of individuals who are at risk.

引用

页码：300 / 306

页数：6

共 116 条

[1]

Soufir N(1998)Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France: the French Familial Melanoma Study Group Hum Mol Genet 7 209-216

[2]

Avril MF(1998)CDKN2A germline mutations in UK patients with familial melanoma and multiple primary melanomas J Invest Dermatol 111 69-272

[3]

Chompret A(1994)Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus Nat Genet 8 23-26

[4]

MacKie RM(1994)Germline p16 mutations in familial melanoma Nat Genet 8 15-21

[5]

Andrew N(1999)Mutation testing in melanoma families: INK4A, CDK4 and INK4D Br J Cancer 80 295-300

[6]

Lanyon WG(1999)CDKN2A (P16INK4a) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas Genes Chromosom Cancer 25 339-348

[7]

Kamb A(1997)Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds Oncogene 15 2999-3005

[8]

Shattuck-Eidens D(1998)The p16INK4a/CDKN2A tumor suppressor and its relatives Biochim Biophys Acta 1378 F115-F177

[9]

Eeles R(1995)Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations N Engl J Med 333 970-974

[10]

Hussussian CJ(1996)Novel germline p16 mutation in familial malignant melanoma in southern Sweden Cancer Res 56 2497-2500

← 1 2 3 4 5 6 7 8 9 10 →